Global Respiratory Therapeutic Devices Market Size, Share, Forecast Report, 2020-2027

Respiratory therapeutic devices are the medical equipment, which is used in the treatment, management, and control of different cardiopulmonary diseases. These devices are extensively used in the treatment of degenerative lung diseases such as chronic obstructive pulmonary diseases (COPD), asthma, acute bronchitis, cystic fibrosis, and others. Increasing prevalence of asthma drives the market along with increasing per capita healthcare expenditure. According to the World Health Organization in 2017, approximately 235 million people suffer from asthma. Moreover, it was estimated that in 2015, the disease killed approximately 383 million patients around the globe. Moreover, the growing geriatric population and increasing adoption of different therapeutic devices like oxygen concentrator, nebulizer and others are projected to fuel the therapeutic respiratory devices market. However, lack of awareness about respiratory conditions and low per capita income in developing countries may hinder the market growth.

The global respiratory therapeutic devices market is expected to grow at an approximate CAGR of 10.8% during the forecast period.
Segmentation

The global respiratory therapeutic devices market is segmented on the basis of product, technology, application, and end users.

On the basis of the product, the market is segmented into nebulizers, capnography, humidifiers oxygen concentrators, and others. The nebulizers segment is sub-segmented into soft mist inhaler, human-powered nebulizer, and others. The capnography segment is sub-segmented into main-stream capnography, side-stream capnography, and others.

On the basis of the technology, the market is segmented into electrostatic filtration, HEPA filtration, hollow fiber filtration, microsphere separation, and others.

On the basis of the application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, retail pharmacies, home care, and others.
Key players in global respiratory therapeutic devices market

Masimo. (U.S.), BD. (U.S.), Smiths Group Plc. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Bayer AG (Europe), Rotech Healthcare Inc. (U.S.), Chart Industries (U.S.), ACare Technology (Asia Pacific), and others.